Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.44 USD | +1.53% | +2.49% | +19.28% |
May. 08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
May. 07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.28% | 3.16B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- JPMorgan Raises IDEAYA Biosciences' Price Target to $35 From $32, Maintains Overweight Rating